A newly published randomized pilot found that people receiving non-ablative fractional laser-assisted delivery of a biomimetic growth-factor serum gained substantially more hair density than participants treated with the energy devices without serum. The study did not directly map every molecular step, so it cannot prove exactly why the combination worked. But research on fractional lasers, transdermal delivery and hair-follicle biology points to a credible two-part mechanism.
First, a 1,927 nm thulium laser creates a microscopic, temporary delivery pathway through the scalp’s outer barrier. Second, the controlled thermal stimulus may trigger repair signals around existing follicles. The serum is therefore applied during a short biological window in which the scalp may be both more permeable and more responsive.
What Is It and How Does It Work?
A 1,927 nm thulium laser is strongly absorbed by water in superficial skin. A fractional device deposits energy in an array of microscopic treatment zones, leaving intervening tissue relatively untouched. Those preserved areas help the skin recover.
The resulting disruption can temporarily reduce the barrier imposed by the stratum corneum and create pathways through which a topical formulation may reach deeper layers more efficiently than it could on intact skin. This matters because growth factors are signalling proteins, not small conventional cosmetic ingredients.
The second component is controlled repair. Microscopic thermal injury can recruit inflammatory cells, vascular signals and tissue-remodelling pathways. Around a miniaturising follicle, those signals may influence dermal papilla cells, epithelial stem cells and the transition from resting telogen toward growing anagen. This is not the same as creating brand-new follicles, and it does not remove the androgen sensitivity that drives pattern hair loss.
The Science: What the Randomized Pilot Tells Us About the Mechanism
In the 2026 randomized controlled pilot, participants received fractional laser plus growth-factor serum and red light, fractional laser plus serum, or fractional laser plus red light without serum. Hair density rose by 25.6% and 22.7% in the serum groups, compared with 4.9% in the energy-device control. Hair thickness improved in both serum groups but not in the control.
Because all groups received fractional laser, the larger response is consistent with the serum contributing an additional effect after laser-assisted delivery. However, there was no serum-only group, so the study cannot isolate improved penetration from the serum’s independent effect. Adding red light increased satisfaction but did not produce a clearly superior density result.
Why the Result Is Biologically Plausible
1. Temporary barrier disruption may improve delivery. A 2024 review of laser- and energy-assisted drug delivery for alopecia concluded that fractional devices can enhance delivery of agents including minoxidil, platelet-rich plasma, corticosteroids, growth factors and cell-derived products. The delivery principle is credible; the ideal wavelength, dose, product and interval are not settled.
2. Controlled injury may activate Wnt/β-catenin signalling. Wnt/β-catenin is central to hair-follicle development and anagen entry. Animal studies of other laser systems report increased Wnt signalling and follicular stem-cell activation. These findings support plausibility but do not prove the same response with a 1,927 nm protocol in human balding scalp.
3. Vascular and repair signals may support the dermal papilla. VEGF helps organise blood-vessel support around growing follicles, while FGF- and IGF-related signalling can affect dermal-papilla activity, survival and epithelial-mesenchymal communication. Key uncertainties include which factors were present, their concentrations, stability and delivered dose.
4. Mild inflammation can be regenerative, but too much can be harmful. Excessive heat, prolonged inflammation, infection or scarring could damage follicles. The desired treatment window is narrow.
5. This may improve existing follicles rather than generate new ones. Changes in density and shaft thickness are compatible with miniaturised follicles producing more visible hairs or thicker shafts, not proof of de novo follicle formation.
What Is Proven, Plausible and Still Unknown?
Proven in this pilot: the serum protocols produced larger six-month density improvements than the laser-plus-red-light control, thickness improved in the serum groups, and no severe adverse events were reported.
Supported by broader evidence: a 2026 systematic review of 15 studies and 1,097 participants found fractional laser therapy improved hair density overall, with mostly temporary redness, discomfort and itching. Heterogeneous protocols mean the pooled result does not validate every clinic treatment.
Read next
Whats the best shampoo for hair loss?
Plausible but unproven here: greater serum penetration; Wnt/β-catenin activation; improved vascular support; inflammation modulation; and stronger dermal-papilla–stem-cell communication.
Still unknown: the serum-only effect, contribution of each growth factor, optimal settings, maintenance, long-term durability, performance against minoxidil or finasteride, and generalisability. Two authors reported lecture fees from Cynosure Lutronic, relevant context for a small pilot.
When Will It Be Available?
Fractional thulium lasers are already used in clinics, but “growth-factor serum” is a broad marketing label. Products vary in source, composition, sterility, storage and evidence. This is an emerging clinician-delivered approach, not a proven home treatment. Applying unverified products to freshly lasered or microneedled skin can increase irritation, contamination and systemic exposure.
How You Can Benefit from This Research Now
Ask for the exact device, wavelength, settings, session schedule and full serum name. Ask whether the product is sterile and intended for disrupted skin, which growth factors it contains, and whether the protocol matches a published study.
Confirm the diagnosis. Sudden shedding, patchy loss, scaling, pain, pustules or scarring require assessment. Discuss standard treatments first: minoxidil and, where appropriate, anti-androgen treatment have much larger evidence bases.
Track progress with photographs under identical lighting, angle, hairstyle and distance. Seek prompt review for worsening pain, spreading redness, blistering, discharge, fever or persistent pigment change.
Sources
- 2026 randomized thulium laser-assisted growth-factor study.
- 2024 review of laser- and energy-assisted drug delivery in alopecia.
- 2026 systematic review and meta-analysis of fractional laser therapy.
- Fractional laser, Wnt10b and hair growth in mice.
- Laser exposure, Wnt/β-catenin and follicle stem-cell research.